FDA Announces New Labeling Guidelines For Longer Acting Painkillers

FDA Announces New Labeling Guidelines For Longer Acting Painkillers

The goal, according to the FDA, is to encourage the safer use of opoids by more responsible and educated prescribing by medical providers. In making these labeling changes, manufacturers of the drugs will also be required to conduct studies regarding

3
Like
Save

Comments

Write a comment

*